Related Experiment Videos

Effective partnerships with long-term care providers

¹American Association of Homes and Services for the Aging, Washington, DC 20004.

Healthcare Executive

|August 6, 1994

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase.

Leukemia·2011

Enzymatic preparation of 5-hydroxy-L-proline, N-Cbz-5-hydroxy-L-proline, and N-Boc-5-hydroxy-L-proline from (α-N-protected)-L-ornithine using a transaminase or an amine oxidase.

Enzyme and microbial technology·2011

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib.

Leukemia·2008

Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy.

Bone marrow transplantation·2003

Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer.

Cytotherapy·2002

A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation.

Bone marrow transplantation·2001

See all related articles